Platelet-Rich Plasma vs. Corticosteroid for Chronic Plantar Fasciitis: A Randomized Trial .
Comparative study of local injections of autologous platelet rich plasma versus corticosteroid in management of chronic plantar fasciitis.
J Clin Orthop Trauma. 2023 Jul 17;43:102225.70 patients with chronic plantar fasciitis were randomized to receive a platelet-rich plasma (PRP) injection (n=35) or a corticosteroid injection (n=35). The primary outcome of interest was pain, as measured on a Visual Analog Scale (VAS) and the American Orthopaedic Foot and Ankle Society (AOFAS) score. Outcomes were assessed at 15 days, and 1, 3, and 6 months post-injection. The results revealed significantly lower VAS pain scores with PRP compared to corticosteroids at 1, 3 and 6 months, and significantly better AOFAS scores at 3 and 6 months. The results of this study suggest that PRP can provide longer-term pain control vs. corticosteroids, particularly in the 3-6 month range. However, the methodological rigour of this study was low, and caution should be taken when extrapolating the results of this study to clinical practice.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
